Electromed demonstrated strong growth in revenue, profitability, and market presence, reflected in record financial results and strategic initiatives like stock repurchases and increased awareness for bronchiectasis. However, challenges like decreased cash balance and increased expenses were noted. The overall sentiment is positive due to the significant highlights outweighing the lowlights.

Company Guidance

During the Electromed Fourth Quarter Fiscal Year 2025 Earnings Conference Call, the company reported record quarterly revenue of $17.4 million, marking a 17% year-over-year increase, which contributed to a record annual net revenue of $64 million. The core home care segment saw a 15% increase, while the hospital and distributor channels surged by 60% and 76%, respectively. Electromed's operating income rose by 30% to $3 million, with a 174 basis point improvement in operating leverage. Net income for the quarter was $2.2 million, a 21% increase from the previous year, with a diluted EPS of $0.25, up 24%. The company completed a $5 million stock repurchase program in Q4 and was included in the Russell 2000 indexes. Electromed ended the fiscal year with 55 sales representatives, up from 53, and achieved productivity exceeding $1 million per representative. The company introduced a new CRM system to enhance sales productivity and maintained strong gross margins of 78.1% for the year. The fiscal year concluded with $15.3 million in cash and no debt, and the company looks forward to leveraging its investments for continued growth in fiscal year 2026.

Record Quarterly Revenue

Electromed achieved record quarterly revenue of $17.4 million, representing a robust 17% year-over-year growth.

Growth Across Key Markets

The core home care segment grew 15%, hospital surged 60%, and the distributor channel delivered 76% growth, driven by strong demand from DME partners.

Increased Profitability

Operating income reached $3 million in Q4, marking a 30% increase year-over-year with improved operating leverage of 174 basis points.

Net Income and EPS Growth

Net income of $2.2 million was 21% higher than the same quarter last year, translating to a diluted earnings per share of $0.25, a 24% increase.

Stock Repurchase Program

Completed a $5 million stock repurchase program in Q4, demonstrating confidence in the company's future and commitment to shareholder value.

Recognition and Index Inclusion

Electromed was recognized as the seventh fastest growing public company in Minnesota and included in the Russell 2000 indexes.

Bronchiectasis Awareness Campaign

The campaign generated over 31,000 views to the dedicated landing page, raising awareness of the disease and highlighting SmartVest therapy.

Manufacturing Optimization and CRM Implementation

Initiated a manufacturing optimization plan and implemented a new CRM system, which is expected to enhance sales productivity and market insights.

Electromed (ELMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ELMD Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 11, 2025	2026 (Q1)	0.20 / -	0.16	―	―	―
Aug 26, 2025	2025 (Q4)	0.22 / 0.25	0.2	25.00% (+0.05)	―
May 13, 2025	2025 (Q3)	0.20 / 0.21	0.17	23.53% (+0.04)	―
Feb 11, 2025	2025 (Q2)	0.18 / 0.22	0.19	15.79% (+0.03)	―
Nov 12, 2024	2025 (Q1)	0.03 / 0.16	0.02	700.00% (+0.14)	―
Aug 27, 2024	2024 (Q4)	0.14 / 0.20	0.12	66.67% (+0.08)	―
May 07, 2024	2024 (Q3)	0.13 / 0.17	0.12	41.67% (+0.05)	―
Feb 13, 2024	2024 (Q2)	0.10 / 0.19	0.11	72.73% (+0.08)	―
Nov 07, 2023	2024 (Q1)	0.10 / 0.02	0.01	100.00% (+0.01)	―
Aug 22, 2023	2023 (Q4)	0.13 / 0.12	0.04	200.00% (+0.08)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ELMD Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 26, 2025	$20.66	$24.77	+19.89%
May 13, 2025	$22.83	$19.34	-15.29%
Feb 11, 2025	$29.20	$33.28	+13.97%
Nov 12, 2024	$26.44	$27.79	+5.11%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Electromed (ELMD) report earnings?

Electromed (ELMD) is schdueled to report earning on Nov 11, 2025, After Close (Confirmed).

What is Electromed (ELMD) earnings time?

Electromed (ELMD) earnings time is at Nov 11, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ELMD EPS forecast?

ELMD EPS forecast for the fiscal quarter 2026 (Q1) is 0.21.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing